Remove 2019 Remove Chronic Condition Remove Patient-Centered Remove Provider
article thumbnail

Psychedelics – reasons for caution: Stacy Fischer, Brian Anderson, Theora Cimino

GeriPal

Potential use in palliative care , chronic pain , and for mood disorders is tantalizing. Early data on efficacy in patients with anxiety and demoralization are promising. In our prior podcast with Ira Byock on psychedelics in 2019 we talked primarily about the potential of psychedelics. Research is exploding.

article thumbnail

Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities

FDA Law Blog

A May 2019 CMS final rule that would have required drug TV advertisements to disclose the WAC of the drug was challenged by a group of pharmaceutical companies and vacated on statutory grounds by the D.C. Controlling Medicare Part D Patient Out-of-Pocket Costs and Total Drug Costs. Controlling Drug Price Increases.